Head & Neck Cancer Staging
- Head and neck cancer staging answers three questions: how big and deep is the tumor (T), has it reached the lymph nodes (N), and has it spread to distant organs (M).
- Most of these cancers are squamous cell carcinomas arising from the mucosa lining the mouth, throat, and voice box — and CT or MRI is how we map their reach.
- The T stage depends heavily on the exact subsite; "deep" and "invading the neighbors" beat "wide and superficial."
- For the oropharynx, whether the tumor is driven by HPV completely changes the staging system used and the outlook.
- Your job on the scan is to trace tumor edges, hunt for suspicious nodes, and flag the structures that turn a curable tumor into an unresectable one.
Imagine you're the building inspector for a very cramped, very important neighborhood — the head and neck. Everything vital is packed into a few inches: the airway, the swallowing tube, big arteries, cranial nerves, and the spine. When a tumor moves in, nobody cares only about its square footage. They care about which walls it has knocked through and which neighbors it's now leaning on. That, in a sentence, is staging.
Why we even bother staging
Staging is just a shared language for "how far has this gone." We use the TNM system: T for the primary tumor, N for the lymph nodes, M for distant spread. Combine the three and you get a stage group that drives the whole plan — surgery, radiation, chemo, or some combination — and gives an honest sense of prognosis.
The overwhelming majority of these tumors are squamous cell carcinomas (SCC) that start in the mucosa — the moist lining of the mouth, throat (pharynx), and voice box (larynx). Risk factors are the classic ones: tobacco, alcohol, and increasingly, human papillomavirus (HPV).
"Head and neck cancer" is not one disease. The oral cavity, oropharynx, larynx, hypopharynx, nasopharynx, and sinuses each have their own T-staging rules because the anatomy that matters is different in each. Always know your subsite before you stage.
The T stage: it's about depth and neighbors, not just width
Early in training I assumed a bigger tumor automatically meant a higher T. Size matters, but for many subsites what really bumps the stage is invasion — tumor punching out of its home turf into something structural.
A tumor of the tongue, for example, is staged partly on depth of invasion: how deep it burrows beneath the surface, not just how wide it spreads across it. Think of a stain on a tablecloth versus a screwdriver jammed through the table — same footprint on top, very different problem underneath.
For other subsites, the upgrade triggers are about which wall the tumor has breached. Has a larynx tumor frozen the vocal cord in place or eaten into cartilage? Has an oral tumor invaded the mandible? These are the findings that move a tumor up the ladder, and they're exactly what cross-sectional imaging is built to show.
The N stage: the lymph node question
Nodes are where head and neck SCC loves to go first, and they often spread in a predictable, level-by-level pattern down the neck. We describe nodal disease using the standardized neck nodal levels (I through VII), which give surgeons and radiation oncologists a precise map.
On imaging, we flag a node as suspicious when it's enlarged, abnormally rounded, or shows central necrosis (a dead, non-enhancing core — a node rotting from the inside). The features that matter most for staging are how many nodes, how big, which side (same side as the tumor, opposite side, or both), and whether tumor has burst through the node's capsule into surrounding fat — extranodal extension.
Extranodal extension is easy to under-call and badly want to ignore, but it's a meaningful adverse feature. Look for a node with a shaggy, ill-defined edge and stranding in the adjacent fat instead of a clean, smooth rim. When present, say so explicitly — it changes management.
The oropharynx deserves its own warning. HPV-related oropharyngeal cancer is staged on a different N system than HPV-negative disease, because those patients tend to do markedly better even with bulky nodes. So the same neck full of nodes can land in very different stage groups depending on HPV status. Don't apply one ruler to both.
The M stage and the "can we even operate" question
M is the simplest box: distant metastasis present or not. The usual far-flung destinations are the lungs, and chest imaging is standard. FDG-PET/CT is often used to sweep for distant disease and unknown primaries, because tumor lights up brighter than normal tissue on it.
Beyond TNM, the report has to answer a separate, blunt question the surgeon is desperate to know: is this resectable? Certain encounters change the answer. Tumor wrapping a large arc around the carotid artery (classically when it surrounds most of the circumference), invading the deep prevertebral muscles, or extending down into the mediastinum can render a tumor unresectable. Knowing the neck spaces is what lets you describe these relationships cleanly.
TNM tells you the stage; the structures the tumor touches tell you whether surgery is even on the table. Report both. A perfectly staged tumor that's wrapped around the carotid is still a different conversation than one sitting in clean fat.
Putting it together on the scan
A contrast-enhanced neck CT is the workhorse, with MRI often added for soft-tissue detail (tongue, skull base, perineural spread) and PET/CT for the whole-body view. However the protocol is built, your reading routine is the same:
| Step | What you're answering | What to look for |
|---|---|---|
| Primary (T) | How deep, how far, which structures? | Tumor margins, depth, cartilage/bone invasion, midline crossing |
| Nodes (N) | Any, how many, which side, any rupture? | Enlarged/round/necrotic nodes by level; extranodal extension |
| Metastasis (M) | Spread beyond the neck? | Lung nodules; distant uptake on PET |
| Resectability | Off-limits structures involved? | Carotid encasement, prevertebral or mediastinal invasion |
Get those four lines right and you've done the job. The single thing to carry away: head and neck staging isn't about how big the tumor looks — it's about what it has touched, which nodes it has colonized, and whether the surgeon still has a clean plane to work in.